A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 149,045 shares of COGT stock, worth $1.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
149,045
Previous 101,531 46.8%
Holding current value
$1.77 Million
Previous $682,000 84.16%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.01 - $9.04 $285,559 - $429,526
47,514 Added 46.8%
149,045 $1.26 Million
Q1 2024

May 09, 2024

SELL
$4.38 - $9.02 $1,138 - $2,345
-260 Reduced 0.26%
101,531 $682,000
Q4 2023

Mar 05, 2024

BUY
$4.06 - $10.08 $1,055 - $2,620
260 Added 0.26%
101,791 $598,000
Q4 2023

Feb 06, 2024

BUY
$4.06 - $10.08 $133,825 - $332,256
32,962 Added 48.07%
101,531 $597,000
Q3 2022

Nov 08, 2022

BUY
$9.39 - $16.99 $643,862 - $1.16 Million
68,569 New
68,569 $1.02 Million

Others Institutions Holding COGT

About Cogent Biosciences, Inc.


  • Ticker COGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,758,300
  • Market Cap $781M
  • Description
  • Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...
More about COGT
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.